Harmony Biosciences Holdings Inc (HRMY)
34.21
-0.97
(-2.76%)
USD |
NASDAQ |
Jan 08, 13:01
Harmony Biosciences Holdings Research and Development Expense (Annual): 76.06M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Arrowhead Pharmaceuticals Inc | 505.87M |
| Incyte Corp | 1.628B |
| Regeneron Pharmaceuticals Inc | 4.439B |
| Vertex Pharmaceuticals Inc | 3.69B |
| Avidity Biosciences Inc | 190.97M |